Suppr超能文献

CRISPR-Cas9基因编辑技术在癌症研究中的应用综述。

Review of applications of CRISPR-Cas9 gene-editing technology in cancer research.

作者信息

Zhao Ziyi, Li Chenxi, Tong Fei, Deng Jingkuang, Huang Guofu, Sang Yi

机构信息

The Third Affiliated Hospital of Nanchang University, Nanchang, 330008, China.

Orthodontic Department of Affiliated Stomatological Hospital of Nanchang University, Nanchang, 330008, China.

出版信息

Biol Proced Online. 2021 Jul 15;23(1):14. doi: 10.1186/s12575-021-00151-x.

Abstract

Characterized by multiple complex mutations, including activation by oncogenes and inhibition by tumor suppressors, cancer is one of the leading causes of death. Application of CRISPR-Cas9 gene-editing technology in cancer research has aroused great interest, promoting the exploration of the molecular mechanism of cancer progression and development of precise therapy. CRISPR-Cas9 gene-editing technology provides a solid basis for identifying driver and passenger mutations in cancer genomes, which is of great value in genetic screening and for developing cancer models and treatments. This article reviews the current applications of CRISPR-Cas9 gene-editing technology in various cancer studies, the challenges faced, and the existing solutions, highlighting the potential of this technology for cancer treatment.

摘要

癌症以多种复杂突变为特征,包括癌基因激活和肿瘤抑制基因抑制,是主要死因之一。CRISPR-Cas9基因编辑技术在癌症研究中的应用引起了极大兴趣,推动了对癌症进展分子机制的探索以及精准治疗的发展。CRISPR-Cas9基因编辑技术为识别癌症基因组中的驱动突变和乘客突变提供了坚实基础,这在基因筛查以及开发癌症模型和治疗方法方面具有重要价值。本文综述了CRISPR-Cas9基因编辑技术在各类癌症研究中的当前应用、面临的挑战以及现有的解决方案,突出了该技术在癌症治疗方面的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b3d/8281662/3ce8cef656d9/12575_2021_151_Fig1_HTML.jpg

相似文献

1
Review of applications of CRISPR-Cas9 gene-editing technology in cancer research.
Biol Proced Online. 2021 Jul 15;23(1):14. doi: 10.1186/s12575-021-00151-x.
2
CRISPR/Cas9-mediated noncoding RNA editing in human cancers.
RNA Biol. 2018 Jan 2;15(1):35-43. doi: 10.1080/15476286.2017.1391443. Epub 2017 Nov 9.
3
The Potential Therapeutic Applications of CRISPR/Cas9 in the Treatment of Gastrointestinal Cancers.
Curr Mol Med. 2025;25(3):278-288. doi: 10.2174/0115665240243076231116080113.
4
5
CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
Protein Pept Lett. 2020;27(10):931-944. doi: 10.2174/0929866527666200407112432.
6
CRISPR-Cas9 therapies in experimental mouse models of cancer.
Future Oncol. 2018 Aug;14(20):2083-2095. doi: 10.2217/fon-2018-0028. Epub 2018 Jul 20.
7
Applications of CRISPR/Cas9 Technology in the Treatment of Lung Cancer.
Trends Mol Med. 2019 Nov;25(11):1039-1049. doi: 10.1016/j.molmed.2019.07.007. Epub 2019 Aug 15.
8
Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications.
J Control Release. 2017 Nov 28;266:17-26. doi: 10.1016/j.jconrel.2017.09.012. Epub 2017 Sep 11.
9
A glance at genome editing with CRISPR-Cas9 technology.
Curr Genet. 2020 Jun;66(3):447-462. doi: 10.1007/s00294-019-01040-3. Epub 2019 Nov 5.
10
Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment.
Clin Genet. 2020 Jan;97(1):73-88. doi: 10.1111/cge.13589. Epub 2019 Jul 10.

引用本文的文献

3
Advances and applications of CRISPR/Cas-mediated interference in .
Eng Microbiol. 2023 Nov 2;4(1):100123. doi: 10.1016/j.engmic.2023.100123. eCollection 2024 Mar.
4
Revitalizing oral cancer research: Crispr-Cas9 technology the promise of genetic editing.
Front Oncol. 2024 Jun 10;14:1383062. doi: 10.3389/fonc.2024.1383062. eCollection 2024.
5
A review of the literature on the use of CRISPR/Cas9 gene therapy to treat hepatocellular carcinoma.
Oncol Res. 2024 Feb 6;32(3):439-461. doi: 10.32604/or.2023.044473. eCollection 2024.
6
3Bs of CRISPR-Cas mediated genome editing in plants: exploring the basics, bioinformatics and biosafety landscape.
Physiol Mol Biol Plants. 2023 Dec;29(12):1825-1850. doi: 10.1007/s12298-023-01397-3. Epub 2023 Dec 7.
7
Genome-wide loss-of-function screen using human pluripotent stem cells to study virus-host interactions for SARS-CoV-2.
Stem Cell Reports. 2023 Sep 12;18(9):1766-1774. doi: 10.1016/j.stemcr.2023.07.003.
8
Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges.
Mil Med Res. 2023 Jul 17;10(1):32. doi: 10.1186/s40779-023-00468-6.
9
CRISPR medicine for blood disorders: Progress and challenges in delivery.
Front Genome Ed. 2023 Jan 6;4:1037290. doi: 10.3389/fgeed.2022.1037290. eCollection 2022.

本文引用的文献

1
2
CHANGE-seq reveals genetic and epigenetic effects on CRISPR-Cas9 genome-wide activity.
Nat Biotechnol. 2020 Nov;38(11):1317-1327. doi: 10.1038/s41587-020-0555-7. Epub 2020 Jun 15.
3
Regulation of laryngeal squamous cell cancer progression by the lncRNA RP11-159K7.2/miR-206/DNMT3A axis.
J Cell Mol Med. 2020 Jun;24(12):6781-6795. doi: 10.1111/jcmm.15331. Epub 2020 May 4.
5
6
In situ CRISPR-Cas9 base editing for the development of genetically engineered mouse models of breast cancer.
EMBO J. 2020 Mar 2;39(5):e102169. doi: 10.15252/embj.2019102169. Epub 2020 Jan 13.
7
Not only cigarettes - other culprits of lung cancer.
Ann Agric Environ Med. 2019 Dec 19;26(4):661-664. doi: 10.26444/aaem/109688. Epub 2019 Jun 14.
9
Modeling Breast Cancer Using CRISPR-Cas9-Mediated Engineering of Human Breast Organoids.
J Natl Cancer Inst. 2020 May 1;112(5):540-544. doi: 10.1093/jnci/djz196.
10
Breast cancer statistics, 2019.
CA Cancer J Clin. 2019 Nov;69(6):438-451. doi: 10.3322/caac.21583. Epub 2019 Oct 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验